Cargando…
The Effect of Testosterone Replacement Therapy on Prostate-Specific Antigen (PSA) Levels in Men Being Treated for Hypogonadism: A Systematic Review and Meta-Analysis
Testosterone replacement therapy is used for the treatment of age-related male hypogonadism, and prostate-specific antigen (PSA) is a primary screening tool for prostate cancer. The systematic review and meta-analysis aimed to determine the effect of testosterone replacement therapy on PSA levels. M...
Autores principales: | Kang, De-Ying, Li, Hong-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602637/ https://www.ncbi.nlm.nih.gov/pubmed/25621688 http://dx.doi.org/10.1097/MD.0000000000000410 |
Ejemplares similares
-
Prostate-Specific Antigen Concentrations in Response to Testosterone Treatment of Severely Hypogonadal Men
por: Sachdev, Saachi, et al.
Publicado: (2020) -
Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy
por: Shoskes, Daniel A, et al.
Publicado: (2015) -
Testosterone Replacement Therapy and Bone Mineral Density in Men with Hypogonadism
por: Kim, Se Hwa
Publicado: (2014) -
Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy
por: Ide, Veerle, et al.
Publicado: (2020) -
Testosterone replacement in male hypogonadism
por: Kalra, Sanjay, et al.
Publicado: (2010)